PHP
NARI

Parkman Healthcare Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Parkman Healthcare Partners’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77,223
Closed -$3.94M – 109
2024
Q4 		$3.94M Buy
77,223
+32,922
+74% +$1.62M 0.53% 51
2024
Q3 		$1.83M Sell
44,301
-151,266
-77% -$7.26M 0.23% 78
2024
Q2 		$9.42M Buy
195,567
+70,229
+56% +$3.11M 1.26% 29
2024
Q1 		$6.01M Buy
+125,338
New +$6.7M 0.74% 48

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Parkman Healthcare Partners's NARI Position: Q1 2025 in Review

Parkman Healthcare Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 77,223 shares — an estimated $3.94M sold.

Parkman Healthcare Partners first reported a position in NARI in Q1 2024 and held it in 4 quarters. The position peaked at $9.42M in Q2 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Parkman Healthcare Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 77,223 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $3.94M.
  • Parkman Healthcare Partners first reported a position in Inari Medical, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
  • Parkman Healthcare Partners's Inari Medical, Inc. Common Stock position peaked at $9.42M in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.